Literature DB >> 11261879

The use of immunoliposomes for specific delivery of antimicrobial agents to oral bacteria immobilized on polystyrene.

A M Robinson1, J E Creeth, M N Jones.   

Abstract

Antibacterial immunoliposomes have been prepared using covalently bound antibody, raised to the cell surface of the bacterium Streptococcus oralis (S. oralis), and incorporating the bactericides chlorhexidine and Triclosan. A regrowth assay, in which the ability of a bacterial biofilm immobilised on polystyrene to grow after exposure to a test solution, was undertaken to study the action of the antibacterial immunoliposomes. The antibacterial anti-oralis immunoliposomes show enhanced growth inhibition of S. oralis, compared to free bactericide, using low bactericide concentrations. For short exposure times to the biofilms, antibacterial anti-oralis immunoliposomes can show several times enhanced growth inhibition of S. oralis compared to free bactericide. Antibacterial anti-oralis immunoliposomes inhibit the growth of S. oralis more than that of other oral bacteria. The extent of growth inhibition by antibacterial anti-oralis immunoliposomes is linearly related to the number of immunoliposomes targeted to the biofilm surface.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11261879     DOI: 10.1163/156856200744408

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  7 in total

1.  pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence.

Authors:  Benjamin Horev; Marlise I Klein; Geelsu Hwang; Yong Li; Dongyeop Kim; Hyun Koo; Danielle S W Benoit
Journal:  ACS Nano       Date:  2015-02-13       Impact factor: 15.881

2.  Nanoparticles for Oral Biofilm Treatments.

Authors:  Danielle S W Benoit; Kenneth R Sims; David Fraser
Journal:  ACS Nano       Date:  2019-04-29       Impact factor: 15.881

Review 3.  Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection.

Authors:  Wanessa C M A de Melo; Pinar Avci; Milene Nóbrega de Oliveira; Asheesh Gupta; Daniela Vecchio; Magesh Sadasivam; Rakkiyappan Chandran; Ying-Ying Huang; Rui Yin; Livia R Perussi; George P Tegos; Janice R Perussi; Tianhong Dai; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-07       Impact factor: 5.091

4.  Enhanced eradication of intracellular and biofilm-residing methicillin-resistant Staphylococcus aureus (MRSA) reservoirs with hybrid nanoparticles delivering rifampicin.

Authors:  Pengbo Guo; Hui Yi Xue; Bettina A Buttaro; Ngoc T Tran; Ho Lun Wong
Journal:  Int J Pharm       Date:  2020-08-30       Impact factor: 5.875

5.  Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms.

Authors:  Pengbo Guo; Bettina A Buttaro; Hui Yi Xue; Ngoc T Tran; Ho Lun Wong
Journal:  Eur J Pharm Biopharm       Date:  2020-04-23       Impact factor: 5.571

Review 6.  Current Trends in Development of Liposomes for Targeting Bacterial Biofilms.

Authors:  Zora Rukavina; Željka Vanić
Journal:  Pharmaceutics       Date:  2016-05-24       Impact factor: 6.321

Review 7.  Current status and future of delivery systems for prevention and treatment of infections in the oral cavity.

Authors:  Sevda Şenel; Ayben Işılay Özdoğan; Gülçin Akca
Journal:  Drug Deliv Transl Res       Date:  2021-03-26       Impact factor: 4.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.